Simplex Trading
AURA icon

Simplex Trading’s Aura Biosciences AURA Stock Holding History

Simplex Trading’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,430
Closed -$60.3K – 9260
2026
Q1 		$56.4K Buy
8,430
+5,796
+220% +$33.3K ﹤0.01% 5740
2025
Q4 		$14.4K Buy
+2,634
New +$15.6K ﹤0.01% 6749
2025
Q2 		– Sell
-54
Closed -$316 – 8594
2025
Q1 		$0 Buy
+54
New +$409 ﹤0.01% 8489
2024
Q4 		– Sell
-16,258
Closed -$144K – 8474
2024
Q3 		$144K Buy
+16,258
New +$139K ﹤0.01% 4852

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Simplex Trading's AURA Position: Q2 2026 in Review

Simplex Trading sold out of Aura Biosciences (AURA) in Q2 2026, closing a stake of 8,430 shares — an estimated $60.3K sold.

Simplex Trading first reported a position in AURA in Q3 2024 and held it in 4 quarters. The position peaked at $144K in Q3 2024. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Simplex Trading reported no remaining Aura Biosciences position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 8,430 Aura Biosciences shares in Q2 2026, an estimated $60.3K.
  • Simplex Trading first reported a position in Aura Biosciences in Q3 2024 and held it in 4 quarters.
  • Simplex Trading's Aura Biosciences position peaked at $144K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.